Gene-toxin interaction as a putative risk factor for Parkinson's disease with dementia

Neuroepidemiology

Volumn 17, Issue 2, 1998, Pages 96-104

  Hubble, J P ^a,e   Kurth, J H ^c   Glatt, S L ^a   Kurth, M C ^c   Schellenberg, G D ^d   Hassanein, R E S ^b   Lieberman, A ^c   Koller, W C ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

^d Geriatric Research Education and Clinical Center   (United States)

^e THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Cytochrome P450; Dementia; Parkinson's disease; Pesticides

Indexed keywords

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; DEMENTIA; EDUCATION; ENVIRONMENTAL FACTOR; FEMALE; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; ONSET AGE; PARKINSON DISEASE; RISK ASSESSMENT;

AGED; APOLIPOPROTEINS; CASE-CONTROL STUDIES; COMORBIDITY; DEBRISOQUIN; DEMENTIA; ENVIRONMENTAL EXPOSURE; FEMALE; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; PARKINSON DISEASE; PESTICIDES; RISK FACTORS; TOXINS, BIOLOGICAL; VARIATION (GENETICS);

EID: 0031916760     PISSN: 02515350     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026159     Document Type: Article

References (52)

1. Cummings JL: Intellectual impairment in Parkinson's disease: Clinical, pathological and biochemical correlates. J Geriatr Psychiatry Neurol 1988;1:24-36.
2. Hietanen M, Teravainen H: The effect of age of disease onset on neuropsychological performance in Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:244-249.
3. Mayeux R, Denary J, Hemenegildo N, Marder K, Tang MX, Cote LJ, Stern Y: A population-based investigation of Parkinson's disease with and without dementia: Relationship to age and gender. Arch Neurol 1992;49:492-497.
4. Stern Y, Marder K, Tang MX, Mayeux R: Antecedent clinical features associated with dementia in Parkinson's disease. Neurology 1993;43:1690-1692.
5. Glatt SL, Hubble JP, Lyons K, Paolo A, Troster AI, Hassanein RE, Koller WC: Risk factors for dementia in Parkinson's disease. Neuroepidemiology 1996;15:20-25.
6. Saunders AM, Strittmatter WJ, Shmechal D, George-Hyslop PH, Pericak-Vance MA, Joo SH, Rosi BL, Gusella JF, Crappe-MacLachan DR, Alberts MJ: Association of apolipoprotein E allele 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43: 1467-1472.
7. Marder K, Maestre G, Cote L, Mejia H, Alfaro B, Halim A, Tang M, Tycko B, Mayeux R: The apolipoprotein ε4 allele in Parkinson's disease with and without dementia. Neurology 1994;44:1330-1331.
8. Koller WC, Glatt SL, Hubble JP, Paolo A, Troster AI, Handler MS, Horvat RT, Martin C, Schmidt K, Karst A: Apolipoprotein E geno-types in Parkinson's disease with and without dementia. Ann Neurol 1995;37:242-245.
9. Koller WC, Vetere-Overfield BM, Gray C, Alexander C, Chin T, Dolezal J, Hassanein R, Tanner C: Environmental risk factors in Parkinson's disease. Neurology 1990;40: 1218-1221.
10. Hubble JP, Cao T, Hassanein RES, Neuberger JS, Koller WC: Risk factors for Parkinson's disease. Neurology 1993;43:1693-1697.
11. Lazzarini AM, Myers RH, Zimmerman TR, Mark MH, Golbe LI, Sage JI, Johnson WG, Duvoisin RC: A clinical genetic study of Parkinson's disease: Evidence for dominant transmission. Neurology 1994;44: 499-506.
12. 450 CYP2D6 allelic frequencies in Parkinson's disease. Am J Med Genet 1993;48:166-168.
13. Planté-Bordeneuve V, Davis MB, Maraganore DM, Marsden CD, Harding AE: Debrisoquine hydroxylase gene polymorphism in familial Parkinson's disease. J Neurol Neurosurg Psychiatry 1994;57:991-913.
14. Kurth JH, Kurth MC, Poduslo SE, Schwankhaus JD: Association of a monoamine oxidase B allele with Parkinson's disease. Ann Neurol 1993;33:368-372.
15. Kuiper MA, Konings CH, Bergmans PL, Wolters EC: Whole blood monoamine oxidase activity in Parkinson's disease and multiple system atrophy patients. J Neurol Sci 1993;117:41-45.
16. Diederich N, Hilger C, Goetz CG, Keipes M, Hentges F, Vieregge P, Metz H: Genetic variability of the CYP 2D6 gene is not a risk factor for sporadic Parkinson's disease. Ann Neurol 1996;40:463-465.
17. Lang AE, Fahn S: Assessment of Parkinson's disease; in Munsat TL (ed): Quantification of neurologic deficit. Boston, Butterworth, 1989, pp 285-309.
18. Mattis S: Dementia Rating Scale: Professional Manual. Odessa, Psychological Assessment Resources, 1988.
19. 450 CYP2D locus. Nature 1990;347:773-776.
20. Hayashi S-I, Watanabe J, Nakachi K, Kawajiri K: PCR detection of an A/G polymorphism within exon 7 of the CYP1A1 gene. Nucleic Acids Res 1991;19:4797.
21. Emi M, Wu LL, Robertson MA, Myers RL, Hegele RA, Williams RR, White R: Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics 1988;3:373-379.
22. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31: 545-548.
23. Cauley JA, Eichner J, Kamboth MI, Ferrell RE, Kuller LH: ApoE allele frequencies in young (age 42-50) vs older (age 65-90) women. Genet Epidemiol 1993;10:27-34.
24. Jarvik GP, Wijsman EM, Kukull WA, Schellenberg GD, Yu C, Larson EB: Interactions of apolipoprotein E genotype, total cholesterol level, age and sex in prediction of Alzheimer disease in a case-control study. Neurology 1995;45:1092-1096.
25. Rajput AH, Uitti RJ, Stern W, Laverty W: Early onset Parkinson's disease in Saskatchewan: Environmental considerations for etiology. Can J Neurol Sci 1986;13:212-216.
26. Barbeau A, Toy M, Bernier G, Campanella G, Paris S: Ecogenetics of Parkinson's disease: Prevalence and environmental aspects in rural areas. Can J Neurol Sci 1987;14:36-41.
27. Semchuk KM, Love EJ, Lee RG: Parkinson's disease and exposure to agricultural work and pesticide chemicals. Neurology 1992;42: 1328-1335.
28. Butterfield PG, Valanis BG, Spencer PS, Lindmena CA; Nutt JG: Environmental antecedents of young-onset Parkinson's disease. Neurology 1993;43:1150-1158.
29. Sanchez-Ramos JR, Hefti F, Weiner WJ: Paraquat and Parkinon's disease (letter). Neurology 1987;37: 728.
30. Sechi GP, Agnetti V, Piredda M, Canu M, Deserra F, Omar HA, Rosati G: Acute and persistent parkinsonism after use of diquat. Neurology 1992;42:261-263.
31. The Canadian Study of Health and Aging: The Canadian Study of Health and Aging: Risk factors for Alzheimer's disease in Canada. Neurology 1994;44:2073-2080.
32. Zhang MY, Katzman R, Salmon D, Jin H, Cai GJ, Wang ZY, Qu GY, Grant J, Yu E, Levy P: The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education. Ann Neurol 1990;27:428-437.
33. Kondo K, Niino M, Shido K: A case-control study of Alzheimer's disease in Japan - Significance of life-styles. Dementia 1994;5:314-326.
34. Mortel KF, Meyer JS, Herod B, Thornby J: Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. Dementia 1995;6:55-62.
35. Ott A, Breteler MM, van Harskamp F, Claus JJ, van der Cammen TJ, Grobbe DE, Hofman A: Prevalence of Alzheimer's disease and vascular dementia: Association with education. The Rotterdam study. Br Med J 1995;310:970-963.
36. Liu HC, Lin KN, Teng EL, Wang SJ, Fuh JL, Guo NW, Chou P, Hu HH, Chiang BN: Prevalence and subtypes of dementia in Taiwan: A community survey of 5,297 individuals. J Am Geriatr Soc 1995;43: 144-149.
37. Katzman R: Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993; 43:13-20.
38. Stern Y, Tang MX, Denaro J, Mayeux R: Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol 1995;37:590-595.
39. Teri L, McCurry SM, Edland SD, Kukull WA, Larson EB: Cognitive decline in Alzheimer's disease: A longitudinal investigation of risk factors for accelerated decline. J Gerontol 1995;50A:M49-55.
40. Cobb JL, Wolf PA, Au R, White R, D'Agostino RB: The effect of education on the incidence of dementia and Alzheimer's disease in the Framingham Study. Neurology 1995;45: 1707-1712.
41. Marder K, Tang MX, Cote L, Stern Y, Mayeux R: The frequency and associated risk factors for dementia in patients with Parkinson's disease. Arch Neurol 1995;52:695-701.
42. Langston JW, Irwin I, Langston EB, Forno LS: Pargyline prevents MPTP induced parkinsonism in primates. Science 1984;225:1480-1482.
43. Shahi GS, Das NP, Moochhala SM: 1-Methyl-4-phenyl-1,2,3-6-tetrahydropyridine-induced neurotoxicity: Partial protection against striato-nigral dopamine depletion in C57BL/ 6J mice by cigarette smoke exposure and by beta-naphthoflavone pretreatment. Neurosci Lett 1991;127: 247-250.
44. Barbeau A, Cloutier T, Roy M, Plasse L, Paris S, Poirier J: Ecogenetics of Parkinson's disease: 4-Hydroxylation of debrisoquine. Lancet 1985;ii:1213-1216.
45. Tanner CM, Chen B, Wang WZ, Peng ML, Liu ZL, Liang XL, Kao LC, Gilley DW, Schoenberg BS: Environmental factors in the etiology of Parkinson's disease. Can J Neurol Sci 1987;14:419-423.
46. Steventon GB, Heafiled MTE, Waring RH, Williams AC: Xenobiotic metabolism in Parkinson's disease. Neurology 1989;39:883-887.
47. Gudjonsson O, Sanz E, Alvan G, Aquilonius SM, Reviriego J: Poor hydroxylator phenotype of debrisoquine and S-mephenytoin are not over-represented in a group of patients with Parkinson's disease (letter). Br J Clin Pharmacol 1990;30: 301-302.
48. Gonzalez FJ, Skoda RC, Kimura S, Umeno M, Zanger UM, Nebert DW, Gelboin HV, Hardwick JP, Meyer UA: Characterisation of the common genetic defect in humans deficient in debrisoquine metabolism. Nature 1988;331:442-446.
49. Kurth JH, Hubble JP, Eggers EA, Kurth M, Glatt S, Koller WC, Lieberman A: Lack of association of CYP2D6 and MAO-B alleles with Parkinson's disease in a Kansas cohort. Neurology 1995;45(suppl 4): A429.
50. Slatkin NE, Flanagan SD, Buain C, Gysin R: Genetic factors in Parkinson's age of onset: Variants at the cytochrome P-450 II-D6 locus. Neurology 1994;44(suppl 2):A115.
51. St George-Hyslop P, McLachlan DC, Tsuda T, Rogaev E, Karlinsky H, Lippa CF, Pollen D, Tuda T: Alzheimer's disease and possible gene interaction (letter). Science 1994; 263:537.
52. Mayeux R, Ottman R, Maestre G, Ngai C, Tang MX, Ginsberg H, Chun M, Tycko B, Shelanski M: Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease. Neurology 1995;45:555-557.